Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from 4DMedical Ltd ( (AU:4DX) ) is now available.
4DMedical Ltd has announced the application for the quotation of its unlisted Piggyback options under the ASX Listing Rule 2.5, condition 6. This move involves the issuance of 23,470,090 options set to expire on September 1, 2027, reflecting the company’s strategic efforts to enhance its financial instruments and market presence.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd operates in the medical technology industry, focusing on developing advanced imaging solutions. The company is known for its innovative respiratory imaging technology, which aims to enhance diagnostic accuracy and patient outcomes.
Average Trading Volume: 4,370,389
Technical Sentiment Signal: Buy
Current Market Cap: A$1.08B
Find detailed analytics on 4DX stock on TipRanks’ Stock Analysis page.